The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires
Abstract
The peptide binding specificities of HLA-DRB1*0401, DRB1*0101, and DRB1*0701 have been analyzed by the use of large collections of synthetic peptides corresponding to naturally occurring sequences. The results demonstrated that nearly all peptides binding to these DR molecules bear a motif characterized by a large aromatic or hydrophobic residue in position 1 (Y, F, W, L, I, V, M) and a small, noncharged residue in position 6 (S, T, C, A, P, V, I, L, M). In addition, allele-specific secondary effects and secondary anchors were defined, and these parameters were utilized to derive allele-specific motifs and algorithms. By the combined use of such algorithms, peptides capable of degenerate DRB1*0101, DRB1*0401, and DRB1*0701 binding were identified. Additional experiments utilizing a panel of quantitative assays specific for nine additional common DR molecules identified a large set of DR molecules, which includes at least the DRB1*0101, DRB1*0401, DRB1*0701, DRB5*0101, DRB1*1501, DRB1*0901, and DRB1*1302 allelic products, characterized by overlapping peptide-binding repertoires. These results have implications for understanding the molecular interactions involved in peptide-DR binding, as well as the genetic and structural basis of MHC polymorphism. These results also have potential practical implications for the development of epitope-based prophylactic and therapeutic vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
Hepatitis B Virus Immunopathogenesis
Chisari, F. V. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.29 · Cited by 1,609
Lymphokine Production by Human T Cells in Disease States
Romagnani, S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.227 · Cited by 1,343
The Regulation of Immunity to Leishmania major
Reiner, S. L. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.151 · Cited by 1,297
Sequence analysis of peptides bound to MHC class II molecules
Rudensky, A. Y., Preston-Hurlburt, P., Hong, S.-C., Barlow, A., & Janeway, C. A. (1991) · Nature · doi:10.1038/353622a0 · Cited by 1,075
Immunity to Intracellular Bacteria
Kaufmann, S. H. E. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001021 · Cited by 1,059
Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.
Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, D. A., Lane, W. S., & Strominger, J. L. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.27 · Cited by 887
Dominance and Crypticity of T Cell Antigenic Determinants
Sercarz, E. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.729 · Cited by 855
The Three-Dimensional Structure of Peptide-MHC Complexes
Madden, D. R. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.587 · Cited by 842
Chicz, R. M., Urban, R. G., Lane, W. S., Gorga, J. C., Stern, L. J., Vignali, D. A. A., & Strominger, J. L. (1992) · Nature · doi:10.1038/358764a0 · Cited by 768
Cited by
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
Self-citationCancer vaccines as promising immuno-therapeutics: platforms and current progress
Liu, J., Fu, M., Wang, M., Wan, D., Wei, Y., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01247-x · Cited by 715
Hill, J. A., Southwood, S., Sette, A., Jevnikar, A. M., Bell, D. A., & Cairns, E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.538 · Cited by 713
Self-citationTumor antigen-specific T helper cells in cancer immunity and immunotherapy
Knutson, K. L., & Disis, M. L. (2005) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-004-0653-2 · Cited by 682
Peptide binding predictions for HLA DR, DP and DQ molecules
Wang, P., Sidney, J., Kim, Y., Sette, A., Lund, O., Nielsen, M., & Peters, B. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-568 · Cited by 681
Self-citationNine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
Sette, A., & Sidney, J. (1999) · Immunogenetics · doi:10.1007/s002510050594 · Cited by 635
“…peptide-MHC binding have also been established (Engelhard 1994; Joyce and Natheson 1994; Sette and Grey 1992; Sidney et al. 1998), and the threshold of affinity associated with generation of immune responses has also been elucidated (Schaeffer et al. 1989; Sette et al. 1994; Southwood et al. 1998).”
BackgroundSelf-citationTarke, A., Sidney, J., Kidd, C. K., Dan, J. M., Ramirez, S. I., Yu, E. D., Mateus, J., da Silva Antunes, R., Moore, E., Rubiro, P., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100204 · Cited by 540
Self-citationReverse Vaccinology: Developing Vaccines in the Era of Genomics
Sette, A., & Rappuoli, R. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.017 · Cited by 559
Self-citationImmunogenicity of protein therapeutics
De Groot, A. S., & Scott, D. W. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.07.011 · Cited by 545
The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design
Fleri, W., Paul, S., Dhanda, S. K., Mahajan, S., Xu, X., Peters, B., & Sette, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00278 · Cited by 500
Self-citationBiological Consequences of MHC-II Expression by Tumor Cells in Cancer
Axelrod, M. L., Cook, R. S., Johnson, D. B., & Balko, J. M. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3200 · Cited by 490
Schuler-Thurner, B., Schultz, E. S., Berger, T. G., Weinlich, G., Ebner, S., Woerl, P., Bender, A., Feuerstein, B., Fritsch, P. O., Romani, N., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012100 · Cited by 475
Greenbaum, J., Sidney, J., Chung, J., Brander, C., Peters, B., & Sette, A. (2011) · Immunogenetics · doi:10.1007/s00251-011-0513-0 · Cited by 448
Self-citationVirus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults
Su, L. F., Kidd, B. A., Han, A., Kotzin, J. J., & Davis, M. M. (2013) · Immunity · doi:10.1016/j.immuni.2012.10.021 · Cited by 429
“…of three independent experiments (see also Figure S5). registers: HIV-1 167–179 was previously shown to bind a similar DR allele (Zavala-Ruiz et al., 2004), and HIV-1 171–181 contains the predicted anchor residues for HLA-DR4 (Hammer et al., 1994; Sette et al., 1993; Southwood et al., 1998).”
BackgroundInfluentialCytomegalovirus Vectors Violate CD8 + T Cell Epitope Recognition Paradigms
Hansen, S. G., Sacha, J. B., Hughes, C. M., Ford, J. C., Burwitz, B. J., Scholz, I., Gilbride, R. M., Lewis, M. S., Gilliam, A. N., Ventura, A. B., et al. (2013) · Science · doi:10.1126/science.1237874 · Cited by 432
Immunogenicity of protein therapeutics: The key causes, consequences and challenges
Baker, M., Reynolds, H. M., Lumicisi, B., & Bryson, C. J. (2010) · Self/Nonself · doi:10.4161/self.1.4.13904 · Cited by 372
A Rational Strategy to Design Multiepitope Immunogens Based on Multiple Th Lymphocyte Epitopes
Livingston, B., Crimi, C., Newman, M., Higashimoto, Y., Appella, E., Sidney, J., & Sette, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5499 · Cited by 361
Self-citationPeptide-based therapeutic vaccines for allergic and autoimmune diseases
Larché, M., & Wraith, D. C. (2005) · Nature Medicine · doi:10.1038/nm1226 · Cited by 326
Weiskopf, D., Bangs, D. J., Sidney, J., Kolla, R. V., De Silva, A. D., de Silva, A. M., Crotty, S., Peters, B., & Sette, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505956112 · Cited by 303
Self-citationCloning Genes Encoding MHC Class II-Restricted Antigens: Mutated CDC27 as a Tumor Antigen
Wang, R.-F., Wang, X., Atwood, A. C., Topalian, S. L., & Rosenberg, S. A. (1999) · Science · doi:10.1126/science.284.5418.1351 · Cited by 300
Definition of supertypes for HLA molecules using clustering of specificity matrices
Lund, O., Nielsen, M., Kesmir, C., Petersen, A. G., R�der, G., Justesen, S., Lundegaard, C., Worning, P., Sylvester-Hvid, C., Lamberth, K., et al. (2004) · Immunogenetics · doi:10.1007/s00251-004-0647-4 · Cited by 292
Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach
Nielsen, M., Lundegaard, C., Worning, P., Hvid, C. S., Lamberth, K., Buus, S., Brunak, S., & Lund, O. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth100 · Cited by 278
T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation
Jawa, V., Cousens, L. P., Awwad, M., Wakshull, E., Kropshofer, H., & De Groot, A. S. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.09.006 · Cited by 270
Peters, B., Nielsen, M., & Sette, A. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082119-124838 · Cited by 270
Self-citationHLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis
Wang, J., Jelcic, I., Mühlenbruch, L., Haunerdinger, V., Toussaint, N. C., Zhao, Y., Cruciani, C., Faigle, W., Naghavian, R., Foege, M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.054 · Cited by 268
Day, C. L., Lauer, G. M., Robbins, G. K., McGovern, B., Wurcel, A. G., Gandhi, R. T., Chung, R. T., & Walker, B. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.12584-12595.2002 · Cited by 258
The Peptide Vaccine of the Future
Nelde, A., Rammensee, H.-G., & Walz, J. S. (2021) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r120.002309 · Cited by 205
Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
Stephens, A. J., Burgess-Brown, N. A., & Jiang, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.696791 · Cited by 153
Peptide-based vaccine for cancer therapies
Buonaguro, L., & Tagliamonte, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1210044 · Cited by 110
Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates
DEGROOT, A., MCMURRY, J., & MOISE, L. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.08.002 · Cited by 109
Weiskopf, D., Angelo, M. A., Sidney, J., Peters, B., Shresta, S., & Sette, A. (2014) · Journal of Virology · doi:10.1128/jvi.01108-14 · Cited by 90
Self-citationZinsli, L. V., Stierlin, N., Loessner, M. J., & Schmelcher, M. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.12.024 · Cited by 63
Kumar, S., Mitchell, M. A., Rup, B., & Singh, S. K. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23169 · Cited by 33
Ye, L., Zhao, G., Ma, J., Gan, Q., Luo, N., Pan, D., Chen, C., Chen, X., & Ning, S. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02769-3 · Cited by 10
Haghighatlari, M., Marze, N., Seward, R., Ciarla, A., Hindin, R., Calderini, J., Keenan, B., Dhule, S., Hall-Swan, S., Hickling, T. P., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08500-2 · Cited by 7
Metadata
- Authors
- Southwood, S., Sidney, J., Kondo, A., del Guercio, M.-F., Appella, E., Hoffman, S., Kubo, R. T., Chesnut, R. W., Grey, H. M., & Sette, A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-04-01
- Volume
- 160
- Issue
- 7
- Pages
- 3363-3373
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1944657476
- Cited by
- 665
- References
- 73
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.